Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Targeted and shielded adenovectors for cancer therapySusan J Hedley, Jian Chen, John D Mountz, et al.Infectious Disorders Drug Targets|April 6, 2019
Therapeutic Exploitation of Viral InterferenceImre Kovesdi, Tibor BakacsThe Journal of Gene Medicine|May 2, 2015
Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodiesÁkos Hornyák, Kai S Lipinski, Tamás Bakonyi, et al.Cureus|September 30, 2022
An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 VaccinationTibor Bakacs, Volker Sandig, Imre KovesdiHepatology, Medicine and Policy|October 6, 2018
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needsTibor Bakacs, Rifaat Safadi, Imre KovesdiPharmaceuticals (Basel, Switzerland)|June 1, 2023
Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and AcyclovirTibor Bakacs, Volker Sandig, Imre KovesdiThe Journal of Gene Medicine|December 8, 2007
Promoters influence the kinetics of transgene expression following adenovector gene deliveryPing Chen, Jie Tian, Imre Kovesdi, et al.The Journal of General Virology|December 4, 2003
Adenovirus vector library: an approach to the discovery of gene and protein functionDuncan McVey, Mohammed Zuber, Douglas E Brough, et al.Journal of Virology|November 26, 2010
Recombinant infectious bursal disease virus carrying hepatitis C virus epitopesChitra Upadhyay, Arun Ammayappan, Deendayal Patel, et al.Pageof 4